532 related articles for article (PubMed ID: 22381726)
1. [RÉALITÉ LT, a pharmacoepidemiological study of semiology and therapeutic strategy of patients with schizophrenia treated by antipsychotic loxapine in routine clinical practice].
Cousin FR; Samuelian JC; Saoud M; Schmitt L; Vacheron MN; Vidailhet P; Augendre J; Walter M; Tonelli I; Pascal JC
Encephale; 2012 Feb; 38(1):64-74. PubMed ID: 22381726
[TBL] [Abstract][Full Text] [Related]
2. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
Bret P; Bret MC; Queuille E
Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
[TBL] [Abstract][Full Text] [Related]
3. [Study on clozapine treatment at the Charles Perrens Hospital in Bordeaux, 15 years after its marketing].
Mercier C; Bret P; Bret MC; Queuille E
Encephale; 2009 Sep; 35(4):321-9. PubMed ID: 19748368
[TBL] [Abstract][Full Text] [Related]
4. First generation antipsychotics switch with Risperidone in the treatment of chronic schizophrenic patients.
Popović I; Ravanić D; Popović V; Vladejić S; Stanojević A; Stojanović M
Psychiatr Danub; 2011 Dec; 23(4):384-8. PubMed ID: 22075740
[TBL] [Abstract][Full Text] [Related]
5. [Therapeutics approach of adult patients with acute and chronic psychotic states: REALITE survey].
Cousin FR; Chabannes JP; Guedj MJ; Lachaux B; Pascal JC
Encephale; 2006; 32(4 Pt 1):466-73. PubMed ID: 17099558
[TBL] [Abstract][Full Text] [Related]
6. [Therapeutic alliance, a stake in schizophrenia].
Charpentier A; Goudemand M; Thomas P
Encephale; 2009 Feb; 35(1):80-9. PubMed ID: 19250998
[TBL] [Abstract][Full Text] [Related]
7. Comparison of patient and clinician perspectives in the assessment of antipsychotic medication adherence.
Barbui C; Kikkert M; Mazzi MA; Becker T; Bindman J; Schene A; Nosè M; Helm H; Thornicroft G; Tansella M
Psychopathology; 2009; 42(5):311-7. PubMed ID: 19672133
[TBL] [Abstract][Full Text] [Related]
8. [Catatonia in a 14 year-old girl: treatment with clorazepam and carbamazepine, a 10-year follow-up].
Askenazy F; Dor E; Benoit M; Dupuis G; Serret S; Myquel M; Seddiki Y
Encephale; 2010 Feb; 36(1):46-53. PubMed ID: 20159196
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of loxapine for inhalation in the treatment of agitation in patients with schizophrenia: a randomized, double-blind, placebo-controlled trial.
Allen MH; Feifel D; Lesem MD; Zimbroff DL; Ross R; Munzar P; Spyker DA; Cassella JV
J Clin Psychiatry; 2011 Oct; 72(10):1313-21. PubMed ID: 21294997
[TBL] [Abstract][Full Text] [Related]
10. Combination loxapine and aripiprazole for refractory hallucinations in schizophrenia.
Sokolski KN
Ann Pharmacother; 2011 Jul; 45(7-8):e36. PubMed ID: 21672885
[TBL] [Abstract][Full Text] [Related]
11. [Evolution of the social autonomy scale (EAS) in schizophrenic patients depending on their management].
Leguay D; Rouillon F; Azorin JM; Gasquet I; Loze JY; Arnaud R; Dillenschneider A
Encephale; 2010 Oct; 36(5):397-407. PubMed ID: 21035630
[TBL] [Abstract][Full Text] [Related]
12. [What information do patients with schizophrenia have about their illness and treatment?].
Ferreri M; Rouillon F; Nuss P; Bazin N; Farah S; Djaballah K; Gerard D
Encephale; 2000; 26(5):30-8. PubMed ID: 11192802
[TBL] [Abstract][Full Text] [Related]
13. Inhaled loxapine for agitation revisited: focus on effect sizes from 2 Phase III randomised controlled trials in persons with schizophrenia or bipolar disorder.
Citrome L
Int J Clin Pract; 2012 Mar; 66(3):318-25. PubMed ID: 22226343
[TBL] [Abstract][Full Text] [Related]
14. A two year trial of loxapine succinate in chronic psychotic patients.
Simpson GM; Branchey MH; Lee JH; Varga E
Dis Nerv Syst; 1976 May; 37(5):305-7. PubMed ID: 816626
[TBL] [Abstract][Full Text] [Related]
15. [Pattern and evolution of the prescription of olanzapine during one year: Results of the cohort study ECOL].
Gasquet I; Flandre P; Heurtebize N; Deal C; Perrin E; Chartier F; Fourrier-Réglat A
Encephale; 2009 Feb; 35(1):25-31. PubMed ID: 19250990
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of negative symptoms in outpatients with schizophrenia spectrum disorders treated with antipsychotics in routine clinical practice: findings from the CLAMORS study.
Bobes J; Arango C; Garcia-Garcia M; Rejas J;
J Clin Psychiatry; 2010 Mar; 71(3):280-6. PubMed ID: 19895779
[TBL] [Abstract][Full Text] [Related]
17. Short-term prospective comparison of prepulse inhibition between schizophrenic patients and healthy controls.
Preuss UW; Zimmermann J; Watzke S; Langosch J; Siafarikas N; Wong JW; Hamm A; Weike A
Pharmacopsychiatry; 2011 May; 44(3):102-8. PubMed ID: 21432751
[TBL] [Abstract][Full Text] [Related]
18. Does loxapine have "atypical" properties? Clinical evidence.
Glazer WM
J Clin Psychiatry; 1999; 60 Suppl 10():42-6. PubMed ID: 10340686
[TBL] [Abstract][Full Text] [Related]
19. Rationale and design of the PLACID study: a randomised trial comparing the efficacy and safety of inhaled loxapine versus IM aripiprazole in acutely agitated patients with schizophrenia or bipolar disorder.
San L; Estrada G; Oudovenko N; Vieta E
BMC Psychiatry; 2017 Apr; 17(1):126. PubMed ID: 28376877
[TBL] [Abstract][Full Text] [Related]
20. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]